These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34071799)

  • 1. Day-4 Lille Score Is a Good Prognostic Factor and Early Predictor in Assessing Therapy Response in Patients with Liver Cirrhosis and Severe Alcoholic Hepatitis.
    Foncea CG; Sporea I; Lupușoru R; Moga TV; Bende F; Șirli R; Popescu A
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34071799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.
    Garcia-Saenz-de-Sicilia M; Duvoor C; Altamirano J; Chavez-Araujo R; Prado V; de Lourdes Candolo-Martinelli A; Holanda-Almeida P; Becerra-Martins-de-Oliveira B; Fernandez-de-Almeida S; Bataller R; Caballeria J; Duarte-Rojo A
    Am J Gastroenterol; 2017 Feb; 112(2):306-315. PubMed ID: 27922027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis.
    Forrest EH; Atkinson SR; Richardson P; Masson S; Ryder S; Thursz MR; Allison M;
    J Hepatol; 2018 Mar; 68(3):511-518. PubMed ID: 29175535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic evaluation and management of alcoholic hepatitis.
    Rana R; Wang SL; Li J; Xia L; Song MY; Yang CQ
    Minerva Med; 2017 Dec; 108(6):554-567. PubMed ID: 28602070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis.
    Abu Omar Y; Randhawa T; Attar B; Agrawal R; Wang Y; Pichardo R; Majeed MB; Patel SA
    Cureus; 2019 Nov; 11(11):e6141. PubMed ID: 31886076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.
    Louvet A; Labreuche J; Artru F; Boursier J; Kim DJ; O'Grady J; Trépo E; Nahon P; Ganne-Carrié N; Naveau S; Diaz E; Gustot T; Lassailly G; Cannesson-Leroy A; Canva-Delcambre V; Dharancy S; Park SH; Moreno C; Morgan TR; Duhamel A; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):398-406.e8; quiz e16-7. PubMed ID: 25935634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model of disease severity in alcoholic hepatitis and novel prognostic insights.
    Enciu VT; Ologeanu PM; Călin-Necula AM; Moldoveanu AC; Oprea-Călin G; Fierbinţeanu-Braticevici C
    Rom J Intern Med; 2024 Jun; 62(2):194-202. PubMed ID: 38180800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of conventional scoring systems versus MAGIC score to predict short-term mortality in patients hospitalized for alcoholic hepatitis.
    Iyer A; Devadas K; Varghese A; Sreesh S
    Scand J Gastroenterol; 2020 Nov; 55(11):1318-1323. PubMed ID: 33001708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.
    Díaz LA; Fuentes-López E; Ayares G; Idalsoaga F; Arnold J; Valverde MA; Perez D; Gómez J; Escarate R; Villalón A; Ramírez CA; Hernandez-Tejero M; Zhang W; Qian S; Simonetto DA; Ahn JC; Buryska S; Dunn W; Mehta H; Agrawal R; Cabezas J; García-Carrera I; Cuyàs B; Poca M; Soriano G; Sarin SK; Maiwall R; Jalal PK; Abdulsada S; Higuera-de-la-Tijera F; Kulkarni AV; Rao PN; Salazar PG; Skladaný L; Bystrianska N; Clemente-Sanchez A; Villaseca-Gómez C; Haider T; Chacko KR; Romero GA; Pollarsky FD; Restrepo JC; Castro-Sanchez S; Toro LG; Yaquich P; Mendizabal M; Garrido ML; Marciano S; Dirchwolf M; Vargas V; Jiménez C; Louvet A; García-Tsao G; Roblero JP; Abraldes JG; Shah VH; Kamath PS; Arrese M; Singal AK; Bataller R; Arab JP
    JHEP Rep; 2023 Aug; 5(8):100727. PubMed ID: 37456675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Lille model for predicting the response of severe alcoholic hepatitis to corticosteroid treatment in Japanese patients.
    Suzuki Y; Kakisaka K; Suzuki A; Takahara T; Sasaki T; Sato T; Yonezawa T; Nitta H; Takikawa Y
    Hepatol Res; 2019 Jul; 49(7):758-764. PubMed ID: 30901152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Model for End-stage Liver Disease (MELD) Score in Predicting Prognosis of Patients with Alcoholic Hepatitis.
    Goyal SK; Dixit VK; Jain AK; Mohapatra PK; Ghosh JK
    J Clin Exp Hepatol; 2014 Mar; 4(1):19-24. PubMed ID: 25755531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Kidney Injury (AKI) at Admission Predicts Mortality in Patients With Severe Alcoholic Hepatitis (SAH).
    Khatua CR; Panigrahi MK; Choudhury AK; Nath G; Khandelwal R; Anirvan P; Singh SP
    J Clin Exp Hepatol; 2023; 13(2):225-232. PubMed ID: 36950492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of prognostic scores for alcoholic hepatitis: a retrospective study.
    Božin T; Rob Z; Lucijanić M; Čmarec Buhin L; Grgurević I
    Croat Med J; 2021 Feb; 62(1):17-24. PubMed ID: 33660957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.
    Papastergiou V; Tsochatzis EA; Pieri G; Thalassinos E; Dhar A; Bruno S; Karatapanis S; Luong TV; O'Beirne J; Patch D; Thorburn D; Burroughs AK
    Aliment Pharmacol Ther; 2014 Apr; 39(7):721-32. PubMed ID: 24612165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for end-stage liver disease score versus Maddrey discriminant function score in assessing short-term outcome in alcoholic hepatitis.
    Kadian M; Kakkar R; Dhar M; Kaushik RM
    J Gastroenterol Hepatol; 2014 Mar; 29(3):581-8. PubMed ID: 24117536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outnumbered: Control Prothrombin Time in Maddrey's Discriminant Function Impacts Steroid Use but Not Mortality in Alcoholic Hepatitis.
    Healey M; Sterling RK
    Biology (Basel); 2022 Dec; 11(12):. PubMed ID: 36552342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.
    Zhang M; Wu R; Jiang J; Minuk GY; Niu J
    Alcohol; 2013 Nov; 47(7):553-8. PubMed ID: 24041840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of alcoholic hepatitis: a prospective comparison of scoring systems.
    Lafferty H; Stanley AJ; Forrest EH
    Aliment Pharmacol Ther; 2013 Sep; 38(6):603-10. PubMed ID: 23879668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen proportionate area predicts long-term mortality in patients with alcoholic hepatitis.
    Israelsen M; Misas MG; Koutsoumourakis A; Hall A; Covelli C; Buzzetti E; Prat LI; Roccarina D; Luong TV; Quaglia A; Pinzani M; Tsochatzis EA
    Dig Liver Dis; 2022 May; 54(5):663-668. PubMed ID: 34548258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of scoring systems in predicting early and late mortality in alcoholic hepatitis: whose score is it anyway?
    Palaniyappan N; Subramanian V; Ramappa V; Ryder SD; Kaye P; Aithal GP
    Int J Hepatol; 2012; 2012():624675. PubMed ID: 22988517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.